Clincosm LogoSign in Get a demo

SEXODON: Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03132818
Collaborator
(none)
0
Enrollment
1
Location
19.1
Actual Duration (Months)
0
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Sexual disorders associated with medical aid for procreation have already been demonstrated in several studies. However, few of them are interested in the problem of patients in charge of donating gametes, and if studied, it is often restricted to donating sperm to a small number of patients. For this reason, it would be interesting to study the impact of the intake and in charge and the treatments of the Medical Aid to the Procreation on this population of patients (including the patients treated in donation of sperm but also Those supported in oocyte donation)

Condition or Disease Intervention/Treatment Phase
  • Other: To evaluate the prevalence of sexual disorders in patients receiving AMP

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple
Actual Study Start Date :
Jul 20, 2017
Actual Primary Completion Date :
Feb 20, 2019
Actual Study Completion Date :
Feb 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Patients undergoing AMP with oocyte donation

Other: To evaluate the prevalence of sexual disorders in patients receiving AMP
To evaluate the prevalence of sexual disorders in patients receiving AMP
Couples supported in AMP with sperm donation

Other: To evaluate the prevalence of sexual disorders in patients receiving AMP
To evaluate the prevalence of sexual disorders in patients receiving AMP
Couples supported in AMP intra torque

Other: To evaluate the prevalence of sexual disorders in patients receiving AMP
To evaluate the prevalence of sexual disorders in patients receiving AMP

Outcome Measures

Primary Outcome Measures

  1. Analysis of anonymous sexual well-being questionnaires: one reserved for men, another reserved for women [1 year]

    Analysis of anonymous sexual well-being questionnaires: one reserved for men, another reserved for women

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • Couple, male and female, meeting the legal criteria for access to medically assisted procreation: a couple, a woman under the age of 43, who can testify to a life together. Then breakdown into 3 inclusion groups:

  • Group 1: Patients undergoing AMP with oocyte donation

  • Group 2: couples supported in AMP with sperm donation

  • Group 3: torque supported in intra torque AMP.

Exclusion Criteria:

  • Patients who do not meet the legal criteria for access to the MPA.

  • Patients in charge of Medical Assistance for Procreation "Viral Risk"

  • Patients undergoing medical aid for procreation for pre-existing sexual dysfunction.

  • Patients awaiting embryo reception.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Picardie Amiens Picardie France 80054

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT03132818
Other Study ID Numbers:
  • RNI2016-25 Dr Scheffler
First Posted:
Apr 28, 2017
Last Update Posted:
Jul 17, 2020
Last Verified:
Jul 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire, Amiens
Procreation with donation

Study Results

No Results Posted as of Jul 17, 2020